Immunologic Research

, Volume 60, Issue 2–3, pp 170–176 | Cite as

Predictors of maternal and fetal complications in SLE patients: a prospective study

  • Elisabetta Borella
  • Andrea Lojacono
  • Mariele Gatto
  • Laura Andreoli
  • Marco Taglietti
  • Luca Iaccarino
  • Edoardo Casiglia
  • Leonardo Punzi
  • Angela Tincani
  • Andrea Doria
FRONTIERS IN AUTOIMMUNITY

Abstract

The aim of the study was to evaluate predictors of disease flares during pregnancy and obstetric and fetal complications in a cohort of systemic lupus erythematosus (SLE) patients. One hundred and thirty-two pregnancies in 96 SLE patients were prospectively followed by monthly clinical and laboratory evaluations. Predictors of lupus flares, fetal and obstetric complications during pregnancy were identified performing stepwise logistic regression analysis. Maternal lupus flares occurred in 57 % of pregnancies and were being best predicted by the number of flares before conception. Manifestations during flares were best predicted by the same features occurred before conception: dermatological flares by skin rash, renal flares by nephritis, and hematological flares by hematological abnormalities. There were 110 live births and 22 fetal losses. Among live newborns, 22 % were premature. Fetal loss was best predicted by hypertension at conception; miscarriages by the amount of steroids taken during the last year before conception; stillbirth by the number of flares during the last year before conception; preterm birth by the coexistence of anti-phospholipid antibody syndrome and anti-double-stranded DNA antibody levels before conception; premature rupture of membranes by high ECLAM score during the 6 months before conception, small for gestation age by hypertension at conception; and preeclampsia by positive lupus anticoagulant. Some independent predictors of lupus flares and fetal and obstetric complications were identified, which can help the risk assessment of pregnancy in SLE patients.

Keywords

Pregnancy Systemic lupus erythematosus Flare Fetal complications Obstetric complications 

References

  1. 1.
    Hardy CJ, Palmer BP, Morton SJ, Muir KR, Powell RJ. Pregnancy outcome and family size in systemic lupus erythematosus: a case–control study. Rheumatology. 1999;38:559–63.CrossRefPubMedGoogle Scholar
  2. 2.
    Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008;199(127):e1–6.PubMedGoogle Scholar
  3. 3.
    Lockshin MD, Reinitz E, Druzin ML, Murrman M, Estes D. Lupus pregnancy: case–control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med. 1984;77:893–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Ideguchi H, Ohno S, Uehara T, Ishigatsubo Y. Pregnancy outcomes in Japanese patients with SLE: retrospective review of 55 pregnancies at a university hospital. Clin Rev Allergy Immunol. 2013;44:57–64.CrossRefPubMedGoogle Scholar
  5. 5.
    Smyth A, Oliveira GH, Lahr BD, et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5:2060–8.PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Molad Y, Borkowski T, Monselise A, et al. Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies. Lupus. 2005;14:145–51.CrossRefPubMedGoogle Scholar
  7. 7.
    Chakravarty EF, Colon I, Langen ES, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol. 2005;192:1897–904.CrossRefPubMedGoogle Scholar
  8. 8.
    Foocharoen C, Nanagara R, Salang L, Suwannaroj S, Mahakkanukrauh A. Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): a study at Srinagarind Hospital. J Med Assoc Thail. 2009;92:167–74.Google Scholar
  9. 9.
    Chen CY, Chen YH, Lin HC, Chen SF. Increased risk of adverse pregnancy outcomes for hospitalisation of women with lupus during pregnancy: a nationwide population-based study. Clin Exp Rheumatol. 2010;28:49–55.PubMedGoogle Scholar
  10. 10.
    Ambrosio P, Lermann R, Cordeiro A, Borges A, Nogueira I, Serrano F. Lupus and pregnancy—15 years of experience in a tertiary center. Clin Rev Allergy Immunol. 2010;38:77–81.CrossRefPubMedGoogle Scholar
  11. 11.
    Teh CL, Wong JS, Ngeh NK, Loh WL. Systemic lupus erythematosus pregnancies: a case series from a tertiary, East Malaysian Hospital. Lupus. 2009;18:278–82.CrossRefPubMedGoogle Scholar
  12. 12.
    Björkander S, Bremme K, Persson JO, van Vollenhoven RF, Sverremark-Ekström E, Holmlund U. Pregnancy-associated inflammatory markers are elevated in pregnant women with systemic lupus erythematosus. Cytokine. 2012;59:392–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Doria A, Tincani A, Lockshin MD. Challenges of lupus pregnancies. Rheumatology (Oxford). 2008;47 (suppl3):iii9–12.Google Scholar
  14. 14.
    Imbasciati E, Tincani A, Gregorini G, Doria A, Moroni G, Cabiddu G, Marcelli D. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant. 2009;24:519–25.CrossRefPubMedGoogle Scholar
  15. 15.
    Tincani A, Danieli E, Nuzzo M, et al. Impact of in utero environment on the offspring of lupus patients. Lupus. 2006;15:801–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Ateka-Barrutia O, Khamashta MA. The challenge of pregnancy for patients with SLE. Lupus. 2013;22:1295–308.CrossRefPubMedGoogle Scholar
  17. 17.
    Wallenius M, Salvesen KA, Daltveit AK, Skomsvoll JF. SLE and outcomes in first and subsequent births based on data from a national birth registry. Arthritis Care Res (Hoboken). 2014. doi:10.1002/acr.22373.Google Scholar
  18. 18.
    Lateef A, Petri M. Management of pregnancy in systemic lupus erythematosus. Nat Rev Rheumatol. 2012;8:710–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Bramham K, Hunt BJ, Bewley S, et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol. 2011;38:1906–13.CrossRefPubMedGoogle Scholar
  20. 20.
    Wagner SJ, Craici I, Reed D, et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus. 2009;18:342–7.PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Ritchie J, Smyth A, Tower C, Helbert M, Venning M, Garovic V. Maternal deaths in women with lupus nephritis: a review of published evidence. Lupus. 2012;21:534–41.CrossRefPubMedGoogle Scholar
  22. 22.
    Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1272–7.Google Scholar
  23. 23.
    Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.CrossRefPubMedGoogle Scholar
  24. 24.
    Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.CrossRefPubMedGoogle Scholar
  25. 25.
    Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost. 1995;74:1185–90.PubMedGoogle Scholar
  26. 26.
    Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol. 2013;27:435–47.CrossRefPubMedGoogle Scholar
  27. 27.
    Zen M, Ghirardello A, Iaccarino L, et al. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly. 2010;140:187–201.PubMedGoogle Scholar
  28. 28.
    Doria A, Iaccarino L, Sarzi-Puttini P, et al. Estrogens in pregnancy and systemic lupus erythematosus. Ann NY Acad Sci. 2006;1069:247–56.CrossRefPubMedGoogle Scholar
  29. 29.
    Lin H, Mossman TR, Guilbert L, Tuntipopipat S, Wegmann TG. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol. 1993;151:4562–73.PubMedGoogle Scholar
  30. 30.
    Doria A, Cutolo M, Ghirardello A, et al. Effect of pregnancy on serum cytokines in SLE patients. Arthritis Res Ther. 2012;14:R66.PubMedCentralCrossRefPubMedGoogle Scholar
  31. 31.
    Iaccarino L, Ghirardello A, Zen M, et al. Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus. Reumatismo. 2012;64:314–20.CrossRefPubMedGoogle Scholar
  32. 32.
    Fernández M, Calvo-Alén J, Alarcón GS, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women. Arthritis Rheum. 2005;52:1655–64.CrossRefPubMedGoogle Scholar
  33. 33.
    Doria A, Ghirardello A, Iaccarino L, et al. Pregnancy, cytokines, and disease activity in systemic lupus erythematosus. Arthritis Rheum. 2004;51:989–95.CrossRefPubMedGoogle Scholar
  34. 34.
    Mintz G, Niz J, Gutierrez G, Garcia-Alonso A, Karchmer S. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol. 1986;13:732–9.PubMedGoogle Scholar
  35. 35.
    Petri MA, van Vollenhoven RF, Buyon J, et al. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials. Arthritis Rheum. 2013;65:2143–53.CrossRefPubMedGoogle Scholar
  36. 36.
    Inês L, Duarte C, Silva RS, Teixeira AS, Fonseca FP, da Silva JA. Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study. Rheumatology (Oxford). 2014;53:85–9.CrossRefGoogle Scholar
  37. 37.
    Doria A, Iaccarino L, Ghirardello A, et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med. 2006;119:700–6.CrossRefPubMedGoogle Scholar
  38. 38.
    Urowitz MB, Gladman DD, Ibañez D, et al. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort. Arthritis Care Res (Hoboken). 2012;64:132–7.CrossRefGoogle Scholar
  39. 39.
    Gatto M, Zen M, Ghirardello A, et al. Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev. 2013;12:523–36.CrossRefPubMedGoogle Scholar
  40. 40.
    Sanchez E, Nadig A, Richardson BC, et al. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis. 2011;70:1752–7.PubMedCentralCrossRefPubMedGoogle Scholar
  41. 41.
    Oke V, Wahren-Herlenius M. Cutaneous lupus erythematosus: clinical aspects and molecular pathogenesis. J Intern Med. 2013;273:544–54.CrossRefPubMedGoogle Scholar
  42. 42.
    Carvalheiras G, Vita P, Marta S, et al. Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution. Clin Rev Allergy Immunol. 2010;38:302–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Feld J, Kibari A, Rozenbaum M, et al. The fetal outcomes of pregnancies of Systemic Lupus Erythematosus patients in northern Israel. J Matern Fetal Neonatal Med. 2014;21:1–10.Google Scholar
  44. 44.
    Alshohai S. Outcome of pregnancy in patients with inactive systemic lupus erythematosus and minimal proteinuria. Saudi J Kidney Dis Transplant. 2009;20:802–5.Google Scholar
  45. 45.
    Aggarwal N, Raveendran A, Suri V, Chopra S, Sikka P, Sharm A. Pregnancy outcome in systemic lupus erythematosus: Asia’s largest single centre study. Arch Gynecol Obstet. 2011;284:281–5.CrossRefPubMedGoogle Scholar
  46. 46.
    Canti V, Castiglioni Mt, Rosa S, et al. Pregnancy outcomes in patients with systemic autoimmunity. Autoimmunity. 2012;45:169–75.CrossRefPubMedGoogle Scholar
  47. 47.
    Madazli R, Yuksel MA, Oncul M, Imamoglu M, Yilmaz H. Obstetric outcomes and prognostic factors of lupus pregnancies. Arch Gynecol Obstet. 2014;289:49–53.CrossRefPubMedGoogle Scholar
  48. 48.
    Ostensen M, Clowse M. Pathogenes is of pregnancy complications in systemic lupus erythematosus. Curr Opin Rheumatol. 2013;25:591–6.CrossRefPubMedGoogle Scholar
  49. 49.
    Smyth A, Oliveira GHM, Lahr BD, et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5:2060–8.PubMedCentralCrossRefPubMedGoogle Scholar
  50. 50.
    Kutteh WH, Hinote CD. Antiphospholipid antibody syndrome. Obstet Gynecol Clin North Am. 2014;41:113–32.CrossRefPubMedGoogle Scholar
  51. 51.
    Bouvier S, Cochery-Nouvellon E, Lavigne-Lissalde G, et al. Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study. Blood. 2014;123:404–13.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Elisabetta Borella
    • 1
  • Andrea Lojacono
    • 2
  • Mariele Gatto
    • 1
  • Laura Andreoli
    • 3
  • Marco Taglietti
    • 3
  • Luca Iaccarino
    • 1
  • Edoardo Casiglia
    • 4
  • Leonardo Punzi
    • 1
  • Angela Tincani
    • 3
  • Andrea Doria
    • 1
  1. 1.Rheumatology Unit, Department of MedicineUniversity of PadovaPaduaItaly
  2. 2.Obstetrics and Gynecology UnitSpedali Civili and University of BresciaBresciaItaly
  3. 3.Rheumatology and Clinical Immunology UnitsUniversity HospitalBresciaItaly
  4. 4.Department of MedicineUniversity of PadovaPaduaItaly

Personalised recommendations